.png)
:max_bytes(150000):strip_icc()/CryptoCoinImage_24-2d4ce7ed7cc747b9bcd5e98e06338935.jpg)
© 2022 coin24h.com
ADVERTISEMENT
XDC
Chingari Announces Integration with Wormhole for Cross-Chain Expansion to Aptos
The new LaunchPad will enable users to have access to the latest promising projects on Core Chain. IceCreamSwap LaunchpadMultichain DeFi...
Read moreMETAPIXEL Launches Beta Testing for Gran Saga, Taking Its First Step Towards a Web3 Gaming Ecosystem
This first testing phase does not include Web3 features, and the second and third phases are scheduled for Q2 2023...
Read moreCryptocurrencies To Watch: Week of March 27
Keep an Eye on These Coins The cryptocurrency market had a strong week overall, with nearly all tokens seeing a...
Read more
Crypto Market Weekly Winners: Ripple, XDC Network, and Flare
The cryptocurrency market has taken a breather after rallying in the first half of March on the back of a...
Read moreTop 5 Cryptos Showing Resilience; Expected To Rally This Week
Recently, the market for cryptos has witnessed a notable shift in price movements as they surged from critical support levels....
Read moreCryptocurrency Price Today: Litecoin, Ripple Show Some Gains As SingularityNET Becomes Top Loser
Bitcoin (BTC) and Ethereum (ETH) — two of the most valued crypto coins — managed to rise above the $27,000...
Read more5 Altcoins That Led the Gains in the Crypto Market
BeInCrypto looks at five altcoins that increased the most in this week’s crypto market, specifically from March 17 to 24....
Read moreCidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
Read moreCidara Therapeutics Provides Corporate Update and Reports
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
Read moreCIDARA THERAPEUTICS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
You should read the following discussion and analysis together with our consolidated financial statements and related notes included elsewhere in...
Read moreADVERTISEMENT
